JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P 500 Value ETF
IVE
|
+$2.05B |
| 2 |
iShares S&P 500 Growth ETF
IVW
|
+$1.92B |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.13B |
| 4 |
iShares Russell 1000 Value ETF
IWD
|
+$1.1B |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$1.06B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.24B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.12B |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$989M |
| 4 |
Microsoft
MSFT
|
+$973M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$931M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.54% |
| 2 | Technology | 14.97% |
| 3 | Healthcare | 10.91% |
| 4 | Financials | 10.87% |
| 5 | Consumer Discretionary | 8.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1776
PUT
Lowe's Companies
LOW
$101B
| $8.54M | ﹤0.01% |
99,200
-58,000
| -37% | -$6.34M |
2017 Q1
12 quarters
|
|
|
JRO
1777
DELISTED
Nuveen Floating Rate Income Opportunty Fund
JRO
| $8.53M | ﹤0.01% |
1,147,788
| – | – |
2013 Q2
27 quarters
|
|
|
CGC
1778
Canopy Growth
CGC
$374M
| $8.51M | ﹤0.01% |
59,002
-903
| -2% | -$170K |
2018 Q2
7 quarters
|
|
1779
CAE Inc
CAE
$7.63B
| $8.49M | ﹤0.01% |
672,658
-6,964
| -1% | -$176K |
2014 Q4
21 quarters
|
|
1780
CALL
Target
TGT
$69.5B
| $8.48M | ﹤0.01% |
91,200
-28,100
| -24% | -$3.12M |
2019 Q4
1 quarter
|
|
1781
Veeco
VECO
$3.44B
| $8.47M | ﹤0.01% |
885,522
-51,272
| -5% | -$689K |
2016 Q3
14 quarters
|
|
|
MNR
1782
DELISTED
Monmouth Real Estate Investment Corp
MNR
| $8.47M | ﹤0.01% |
702,605
+377,061
| +116% | +$5.22M |
2015 Q2
19 quarters
|
|
1783
CALL
BioMarin Pharmaceuticals
BMRN
$11.1B
| $8.45M | ﹤0.01% |
100,000
+73,000
| +270% | +$6.29M |
2019 Q4
1 quarter
|
|
1784
Viavi Solutions
VIAV
$11.6B
| $8.43M | ﹤0.01% |
752,296
+83,478
| +12% | +$1.14M |
2013 Q2
27 quarters
|
|
|
VLDR
1785
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
| $8.4M | ﹤0.01% |
+825,910
| New | +$8.42M |
2020 Q1
0 quarters
|
|
|
DRNA
1786
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $8.4M | ﹤0.01% |
457,106
-107,805
| -19% | -$2.1M |
2017 Q1
12 quarters
|
|
1787
Box
BOX
$4.85B
| $8.36M | ﹤0.01% |
595,702
+150,983
| +34% | +$2.25M |
2015 Q3
18 quarters
|
|
1788
Valley National Bancorp
VLY
$7.05B
| $8.35M | ﹤0.01% |
1,142,643
+466,862
| +69% | +$4.57M |
2013 Q2
27 quarters
|
|
1789
Penumbra
PEN
$12.5B
| $8.32M | ﹤0.01% |
51,547
+21,979
| +74% | +$3.7M |
2015 Q3
18 quarters
|
|
1790
PUT
General Motors
GM
$70.4B
| $8.31M | ﹤0.01% |
400,000
-861,400
| -68% | -$26.3M |
2014 Q2
23 quarters
|
|
1791
Harley-Davidson
HOG
$2.73B
| $8.29M | ﹤0.01% |
438,019
-56,319
| -11% | -$1.7M |
2013 Q2
27 quarters
|
|
1792
PUT
Vale
VALE
$60.2B
| $8.29M | ﹤0.01% |
1,000,000
-708,400
| -41% | -$7.71M |
2014 Q4
21 quarters
|
|
1793
iShares Core 1-5 Year USD Bond ETF
ISTB
$5.09B
| $8.27M | ﹤0.01% |
163,833
-1,230,430
| -88% | -$62.1M |
2015 Q1
20 quarters
|
|
1794
Center Bancorp
CNOB
$1.54B
| $8.27M | ﹤0.01% |
615,430
+254,623
| +71% | +$5.36M |
2017 Q3
10 quarters
|
|
1795
CALL
Wheaton Precious Metals
WPM
$61.9B
| $8.26M | ﹤0.01% |
+300,000
| New | +$8.66M |
2020 Q1
0 quarters
|
|
1796
CRISPR Therapeutics
CRSP
$5.54B
| $8.25M | ﹤0.01% |
194,615
-44,014
| -18% | -$2.27M |
2018 Q2
7 quarters
|
|
1797
Marvell Technology
MRVL
$244B
| $8.25M | ﹤0.01% |
364,686
-6,308,157
| -95% | -$151M |
2013 Q2
27 quarters
|
|
1798
uniQure
QURE
$1.58B
| $8.21M | ﹤0.01% |
173,046
+114,889
| +198% | +$6.6M |
2015 Q4
17 quarters
|
|
1799
Workiva
WK
$3.91B
| $8.21M | ﹤0.01% |
253,963
+235,967
| +1,311% | +$9.81M |
2016 Q4
13 quarters
|
|
1800
Dana Inc
DAN
$3.02B
| $8.21M | ﹤0.01% |
1,050,809
+231,053
| +28% | +$3.19M |
2013 Q2
27 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2020 Portfolio in Review
As of Q1 2020, JP Morgan Chase held 6,012 positions worth $426B, down 21% from $536B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase deployed $14B of net new capital in Q1 2020, opening 362 new positions and adding to 2,382 existing holdings. Its largest new stake was NextEra Energy, Inc. 5.279% Corporate Units: 1,245,017 shares worth $54.9M.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was JPMorgan BetaBuilders Japan ETF, an estimated $1.24B trimmed.
- JP Morgan Chase's largest Q1 2020 buy was NextEra Energy, Inc. 5.279% Corporate Units: 1,245,017 shares worth $54.9M.
- JP Morgan Chase added most to iShares S&P 500 Value ETF in Q1 2020, an estimated $2.05B increase.
- JP Morgan Chase's biggest Q1 2020 reduction was JPMorgan BetaBuilders Japan ETF, cutting an estimated $1.24B.
- JP Morgan Chase fully exited Liberty Property Trust in Q1 2020, selling an estimated $264M.
- JP Morgan Chase's ten largest holdings make up 18% of its $426B portfolio in Q1 2020.
- JP Morgan Chase opened 362 new positions and closed 692 in Q1 2020.
- JP Morgan Chase's portfolio value fell 21% quarter-over-quarter to $426B.
Based on JP Morgan Chase's 13F filing for Q1 2020, filed 12 May 2020.